Discovery and SARs of Trans-3-Aryl Acrylic Acids and Their Analogs as Novel Anti- Tobacco Mosaic Virus (TMV) Agents

Wu, Meng; Wang, Ziwen; Meng, Chuisong; Wang, Kailiang; Hu, Yanna; Wang, Lizhong; Wang, Qingmin
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
A series of trans-3-aryl acrylic acids 1–27 and their derivatives 28–34 were prepared and evaluated for their antiviral activity against tobacco mosaic virus (TMV) for the first time. The bioassay results showed that most of these compounds exhibited good antiviral activity against TMV, of which compounds 1, 5, 6, 20, 27 and 34 exhibited significantly higher activity against TMV than commercial Ribavirin both in vitro and in vivo. Furthermore, these compounds have more simple structure than commercial Ribavirin, and can be synthesized more efficiently. These new findings demonstrate that trans-3-aryl acrylic acids and their derivatives represent a new template for antiviral studies and could be considered for novel therapy against plant virus infection.


Related Articles

  • Antiviral treatment of SARS: Can we draw any conclusions? Zhaori, Getu // CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1165 

    Presents opinion on the antiviral therapy of severe acute respiratory syndrome (SARS). Experience with empirical treatment of SARS with ribavirin; Regimens that could be used or another outbreak of SARS.

  • Anti-infectives: Targeting SARS. Jones, Susan // Nature Reviews Microbiology;Sep2004, Vol. 2 Issue 9, p686 

    The article reports developments on the study on severe acute respiratory virus (SARS-CoV) as published in the Proceedings of the National Academy of Sciences in the U.S. Based on the report, fifteen compounds that are potent against the SARS-CoV were identified. They include the ribavirin and...

  • Recent Developments in the Virology and Antiviral Research of Severe Acute Respiratory Syndrome Coronavirus. Kap-Sun Yeung; Meanwell, Nicholas A. // Infectious Disorders - Drug Targets;Mar2007, Vol. 7 Issue 1, p29 

    This article summarizes the significant developments and new discoveries in both the virology and antiviral research associated with the severe acute respiratory syndrome coronavirus (SARS CoV) that were reported in 2005 and 2006. Areas reviewed include genomic studies and the identification of...

  • Anti-Viral Therapies for Hepatitis C Virus Infection: Current Options and Evolving Candidate Drugs. Fanning, Liam J. // Letters in Drug Design & Discovery;Mar2005, Vol. 2 Issue 2, p150 

    Chronic hepatitis C is a ubiquitous disease, affecting approximately 170 million globally. The hepatitis C virus (HCV) is spread by parenteral transmission of body fluids, primarily blood or blood products. The hepatitis C viral genome is a positive-sense, single-stranded RNA molecule...

  • In vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses. Selvam, P.; Murgesh, N.; Chandramohan, M.; De Clercq, E.; Keyaerts, E.; Vijgen, L.; Maes, P.; Neyts, J.; Ranst, M. V. // Indian Journal of Pharmaceutical Sciences;2008, Vol. 70 Issue 1, p91 

    4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N (4,6-dimethyl-2-pyrimidiny)benzene sulphonamide and its derivatives were evaluated for antiviral activity against Pathogenic viruses such as Hepatitis C Virus and SARSCoV in Vero and Huh 5-2 cells, respectively. The 5-fluoro derivative inhibited...

  • Ribavirin for SARS in Children. Wai Tsoi Frankie Cheng, Valerie; Li, Chi Kong; Leung, Ting Fan; Albert Man-chim Li, Valerie; Kam Lun Ellis Hon, Valerie; Pak Cheung Ng, Valerie; Tai Fak Fok, Valerie // Clinical Pediatrics;Mar2004, Vol. 43 Issue 2, p193 

    Investigates the effectiveness of ribavirin for the treatment of SARS in children. Median pretreatment hemoglobin level; Mechanism of action of the drug; Absence of any clinically significant adverse effects associated with high dose of oral and intravenous ribavirin treatment.

  • Clinical Trials and Novel Pathogens: Lessons Learned from SARS. Muller, Matthew P.; McGeer, Allison; Straus, Sharon E.; Hawryluck, Laura; Gold, Wayne L. // Emerging Infectious Diseases;Mar2004, Vol. 10 Issue 3, p389 

    During the recent global outbreak of severe acute respiratory syndrome (SARS), thousands of patients received treatments such as ribavirin and corticosteroids. Despite this, no controlled clinical trials assessing the efficacy of these agents were conducted. If a second global SARS outbreak...

  • The invasion of tobacco mosaic virus RNA induces endoplasmic reticulum stress-related autophagy in HeLa cells. Li LI; Li WANG; Ruijing XIAO; Guoguo ZHU; Yan LI; Changxuan LIU; Ru YANG; Zhiqing TANG; Jie LI; Wei HUANG; Lang CHEN; Xiaoling ZHENG; Yuling HE; Jinquan TAN // Bioscience Reports;Apr2012, Vol. 32 Issue 2, p171 

    The ability of human cells to defend against viruses originating from distant species has long been ignored. Owing to the pressure of natural evolution and human exploration, some of these viruses may be able to invade human beings. If their 'fresh' host had no defences, the viruses could cause...

  • Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin. Gowen, Brian B.; Smee, Donald F.; Min-Hui Wong; Hall, Jeffery O.; Kie-Hoon Jung; Bailey, Kevin W.; Stevens, John R.; Furuta, Yousuke; Morrey, John D. // PLoS ONE;2008, Vol. 3 Issue 11, p1 

    A growing number of arenaviruses are known to cause viral hemorrhagic fever (HF), a severe and life-threatening syndrome characterized by fever, malaise, and increased vascular permeability. Ribavirin, the only licensed antiviral indicated for the treatment of certain arenaviral HFs, has had...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics